Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T16:49:11.933Z Has data issue: false hasContentIssue false
  • English
  • Français

EXPERIENCES IN ADAPTING EUROPEAN NETWORK FOR HEALTH TECHNOLOGY ASSESSMENT RAPID REVIEWS TO INFORM LOCAL DECISION MAKING

Part of: Special Collection - Methods

Published online by Cambridge University Press:  09 June 2017

Karen Macpherson  and
Lorna Thompson
Karen Macpherson
Affiliation:
Healthcare Improvement Scotlandkaren.macpherson@nhs.net
Lorna Thompson
Affiliation:
Healthcare Improvement Scotland
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The Scottish Health Technologies Group (SHTG) produces rapid reviews on nonmedicine technologies to inform advice for decision making in the National Health Service in Scotland (NHSScotland). This study describes our experiences and lessons learned in adapting for NHSScotland two rapid Relative Effectiveness Assessments (REAs) produced as part of the European Network for Health Technology Assessment (EUnetHTA) project to test collaborative preparation and then local adaptation.

Methods: The REAs were examined for their relevance to NHSScotland and the feasibility of their adaptation evaluated using a screening toolkit. Some supplementary literature searches were conducted and additional background information on epidemiology and the specific technologies was sought. To inform decision making within Scotland, it was also necessary to identify and review cost-effective analyses.

Results: Robust evidence reviews were delivered for NHSScotland. Time saved was less than anticipated, partly due to the need to add in health economic information, and partly because of attempts to supplement and update the EUnetHTA material. The preparation of an accompanying advice statement for NHSScotland enabled the inclusion of local contextual information.

Conclusions: Collaborative production and adaptation of HTAs is feasible and would be aided by the inclusion of cost-effectiveness analyses in the original work. Agencies should develop clear processes for adapting such reviews for their context with the focus on selecting appropriate topics for adaptation, avoiding unnecessary supplementation of the original work, and ensuring local ownership of final advice.

Keywords

Technology assessmentBiomedicalScotlandEuropean UnionMethods
Type
Methods
Information
International Journal of Technology Assessment in Health Care , Volume 33 , Issue 2 , 2017 , pp. 155 - 159
Copyright
Copyright © Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Kristensen, FB. Development of European HTA: From vision to EUnetHTA. Michael 2012;9:147–156.Google Scholar
2. European Network for Health Technology Assessment (EUnetHTA). Renal denervation systems for treatment resistant hypertension. 2015. htp://eunethta.eu/sites/5026.fedimbo.belgium.be/files/Renal%20Denervation%20Systems%20for%20treatment-resistant%20hypertension_Rapid%20REA_Final_Dec%202013_0.pdf. (accessed July 21, 2016).Google Scholar
3. European Network for Health Technology Assessment (EUnetHTA). Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation v1.4. 2015. http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/WP5-SB-15_Transcatheter%20implantable%20dvices%20for%20mitral%20valve%20repair.pdf (accessed August 12, 2016).Google Scholar
4. EUnetHTA. Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke. 2015. https://eunethta.fedimbo.belgium.be/sites/5026.fedimbo.belgium.be/files/WP5-SB16_Mechanical%20thrombectomy%20devices%20for%20acute%20ischaemic%20stroke.pdf (accessed August 12, 2016).Google Scholar
5. Healthcare Improvement Scotland. What is the effectiveness, safety and cost-effectiveness of the MitraClip® transcatheter mitral valve repair system in patients with moderate to severe or severe mitral regurgitation who are at high surgical risk or are non-surgical candidates? 2016. http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/shtg_-_evidence_notes/evidence_note_58.aspx (accessed August 12, 2016).Google Scholar
6. Healthcare Improvement Scotland. What is the clinical effectiveness, safety and cost effectiveness of endovascular therapy using mechanical thrombectomy devices for patients with acute ischaemic stroke? 2016. http://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/shtg_-_evidence_notes/evidence_note_61.aspx (accessed August 12, 2016).Google Scholar